Mr Timothy Philp

Mr Timothy PhilipTel: 020 3447 9179
Email: timothy.philp@uclh.nhs.uk

Location:
University College Hospital

Specialities:
Urology

Professional background

Consultant Urological Surgeon at UCLH & Institute of Urology plus Whipps Cross Hospital London.

At UCH Mr Philp concentrates on specialist interests of the treatment of stone disease and the endourological management of obstructions and tumours of upper urinary tract while maintaining a general urological practice at Whipps Cross Hospital where he is the Senior Consultant Urologist.  Mr Philp studied medicine at Trinity College Cambridge and St Thomas’s Hospital and trained in General Surgery and Urology, principally at St Thomas’s, Northampton General and the St Peter’s Group of Urological Hospitals.    Research into bladder function was undertaken at Oxford University, which resulted in a Mastership of Surgery from Cambridge.  Higher surgical training was at St Peter’s and the Institute of Urology.  Where on appointment as a Consultant at Whipps Cross he continued to hold a contract at St Peter’s and The Institute of Urology and now comes to UCLH two days a week to continue his work as a stone and endourological surgeon.

Research interests

  • Renal stone disease
  • Endourological management of upper urinary tract tumours
  • Endoscopic management of upper urinary tract obstructions
  • Urodynamics & Incontinence
  • Surgery for bladder outflow obstruction

Publications

Three Year Follow Up of a Prospective Randomized Trial Comparing Transurethral electrovaporisation of prostate with standard TURP.

  M Hammadeh, S. Madaan, M. Singh, T. Philp.  Brit.U.Urol 2000, 86, 648-651

The self-expanding metallic ureteric stent in the long-term management of benign ureteric strictures.

  M.Arya, H Mostafid, H R H Patel, M J Kellett, T Philp.  Brit.J.Urol 2001, 88, 339 – 342

The rendezvous procedure to cross complicated ureteric strictures.

  J M Watson, G P C Dawkins, H N Whitefield, T Philp, M Kellett.  Brit. J. Urol 2002, 89, 317-319

Management of colonic injury following percutaneous nephrolithotomy.

  M Hussain, R Hamid, M Arya, J L Peter, M J Kellett, T Philp.  Int. J. Clinical Practice 2003, 57, 549-550

Transurethral electovaporization of the prostate (TUVP) is effective, safe and durable. 

  Hammadeh MY, Philp T.  Prostate Cancer Prostatic Disease. 2003;6(2): 121-6.

5-year outcome of a prospective randomised trial to compare transurethral electrovaporization of the
prostate and standard transurethral resection.

  Hammadeh MY, Madaan S, Hines J, Philp T  Urology 2003 Jun;61(6):1166 -71

Dystrophic ureteral calcification associated with Churgh-Strauss vasculitis.

  A Symes, V Kalsi, D Rickards, C Allen, S Choong & T Philp.  Journal of Urology
   Dec 2004, 64, 6 1231

Long-term outcomes in patients with prostate cancer managed with intermittent androgen suppression.  
  T Lane, W Ansell, P Wilson, G Williams, G Chinegwundoh, T Philp, J Hines, R T D Oliver.  Urology International 2004  73, 117-122.

The first semen analysis after vasectomy:timing and definition of success.

  KH Attar, S Holden, J Peters, T Philp.  Brit Journal Urology International 2007
Sep:100(3):700-701

Clearance after Vasectomy: Has the time come to modify the current practice?

  K H Attar, P Gurung, S Holden, J Peter, T Philp   Scand J Urol Nephrol 2010 Mar 5

Percutaneous Urinary Drainage and Ureteric stenting in Malignant Disease.

  D.J. Allen, S.E. Longhorn, T.Philp, R.D. Smith, S.Choong  Clinical Oncology 2010
  22 733-379

GMC/GDC number: 1627309